SAGE THERAPEUTICS INC

CUSIP: 78667J108 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 187,048 Value ($000) $1,487 Avg Close — Range —
Q4 2024
Shares 169,057 Value ($000) $918 Avg Close — Range —
Q3 2024
Shares 65,562 Value ($000) $473 Avg Close — Range —
Q2 2023
Shares 93,329 Value ($000) $4,388 Avg Close — Range —
Q1 2023
Shares 108,622 Value ($000) $4,558 Avg Close — Range —
Q4 2022
Shares 115,665 Value ($000) $4,411 Avg Close — Range —
Q3 2022
Shares 59,183 Value ($000) $2,318 Avg Close — Range —
Q2 2022
Shares 53,643 Value ($000) $1,733 Avg Close — Range —
Q1 2022
Shares 42,503 Value ($000) $1,407 Avg Close — Range —
Q4 2021
Shares 73,377 Value ($000) $3,121 Avg Close — Range —
Q3 2021
Shares 53,833 Value ($000) $2,385 Avg Close — Range —
Q1 2021
Shares 10,596 Value ($000) $793 Avg Close — Range —
Q4 2020
Shares 4,692 Value ($000) $406 Avg Close — Range —